What are drugs and why are they controlled? What are the benefits and harms of taking drugs? How public health policies can address drug use? Learn the answers to these questions and more in the free online course 'Drugs, drug use, drug policy and health'.
In December 2017, the Transnational Institute (TNI) and Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), on behalf of the Federal Ministry of Economic Cooperation and Development of Germany (BMZ), in collaboration with the Thai Office of the Narcotics Control Board (ONCB) and the Mae Fah Luang Foundation under Royal Patronage (MFLF), jointly organised the 9th Asian Informal Drug Policy Dialogue (IDPD) in Chiang Rai, Thailand.
In Myanmar’s Kachin State, a women’s drop-in centre has transformed into more than just a harm reduction facility. Leading up to International Women’s Day, we spoke with Thinzar Tun (AHRN Myanmar) about what makes this centre special.
To address its serious drug use problems, Myanmar should change its drug policy towards a harm reduction approach. Instead of a repressive approach, voluntary and evidence-based treatment and public health services, including harm reduction, should be made available and become generally accepted by enforcement officials and by the community at large.
This International Symposium provides a timely opportunity for practitioners and stakeholders across Europe to discuss the latest challenges and consider the next steps needed to win the fight against illicit drug trafficking and substance misuse through holistic, multi-level and cross-border approaches. Public Policy Exchange welcomes the participation of all key partners, responsible authorities and stakeholders. The Symposium will support the exchange of ideas and encourage delegates to engage in thought-provoking topical debate.
Preparations are gathering pace for the United Nations General Assembly Special Session (UNGASS) on drugs, to be held on the 19th to 21st April 2016 in New York. Following several months of discussion on procedural elements, attention is now focused on negotiating the content of the "short, substantive, concise and action-orientated outcome document comprising a set of operational recommendations" to be approved by the General Assembly next April. At the CND intersessional meeting on 12th June, countries and regional groups were invited to submit their first ideas for what could be included in this Outcome Document, by a deadline of 11th September.
Ecuador has entered a new era in drug policy and legislation. Twenty-five years after the last major legal reform, brought about by the famed Narcotic and Psychotropic Substances Law (Ley de Sustancias Estupefacientes y Psicotrópicas, Law 108), which took effect on September 17, 1990, the National Assembly is about to debate—for the second and final time—the draft Law on Prevention of Drugs and Use or Consumption of Substances Classified as Subject to Oversight (Ley de Prevención de Drogas y Uso y Consumo de Sustancias Catalogadas Sujetas a Fiscalización.)
Luxembourg's Parliament is to debate the decriminalisation of consumption of cannabis, the health minister said while outlining a new drug prevention programme. The minister said she hoped to raise awareness among young people of the risks surrounding cannabis consumption as well as the use of other, legal drugs, such as alcohol and tobacco.
Global disagreement over drug policies provides an important opportunity to reconsider the effectiveness of existing counternarcotics policies, address their problematic side effects, and propose evidence-based alternative strategies. Because of the differences in attitudes on drug policy around the world, a substantial revision of existing counternarcotics treaties is unlikely at UNGASS 2016. (See also: Improving global drug policy: Comparative perspectives and UNGASS 2016)
On 19th to 21st April 2016, there will be a United Nations General Assembly Special Session (UNGASS) held in New York, dedicated to the issue of drug policy. The General Assembly is the highest policy making and representative organ of the United Nations (UN), and its infrequent Special Sessions focus on pertinent topics at the request of member states. The UNGASS on drugs has the potential to be a ground-breaking, open debate about the international drug control system – but there is much work to be done to ensure that it fulfils that potential.
No fewer than six randomised controlled trials – in Switzerland, the Netherlands, Germany, Spain, Canada, and England – concluded that heroin assisted treatment is more effective than conventional treatments in a subgroup of heroin users.